Current Unmet Needs for Patients With Low-Risk MDS in the Frontline Setting
Dr Jamie L. Koprivnikar comments on the currently unmet needs for patients with low-risk myelodysplastic syndrome in the front-line setting.
EP: 1.Case Presentation: A 72-Year-Old Woman with Single Lineage Dysplasia Myelodysplastic Syndrome (MDS)
EP: 2.Approaches to Diagnosis and Risk Assessment for Patients With MDS
EP: 3.Differences in Treatment Approaches for Low-Risk and High-Risk MDS
Now Viewing
EP: 4.Current Unmet Needs for Patients With Low-Risk MDS in the Frontline Setting
EP: 5.Luspatercept as a Treatment Option in MDS
EP: 6.Efficacy and Safety of Luspatercept in MDS: Key Data from the COMMANDS Trial
EP: 7.Rationale Surrounding Luspatercept as Potential First-Line Treatment Option for Patients With MDS
EP: 8.Future Perspectives and Unmet Needs for Patients With MDS
Related Videos
Related Content
